Trial Profile
Pilot Study of the Efficacy of Duloxetine in Treating Adults With Attention Deficit Hyperactivity Disorder: a Randomized, Controlled Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2018
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 02 Jun 2011 Interim results will be presented at the 10th World Congress of Biological Psychiatry.
- 13 Dec 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.